Skip to main content
HairCited

Minoxidil для Alopecia Areata

A

На основе 48 исследований (2 meta-analyses, 1 RCT) с участием 21,842 участников. 37/48 исследований показывают положительные эффекты.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dminoxidil\u0026condition\u003Dalopecia\u002Dareata'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Итог

Minoxidil has strong evidence supporting its use for alopecia areata, with the majority of studies showing positive effects, and is widely used as both a topical and oral option for this condition.

  • 37 out of 48 studies show positive effects across a large pool of 21,842 participants
  • Available in topical (2% and 5%) and oral low-dose formulations
  • Extends the hair growth phase and increases blood supply to hair follicles
  • Often used in combination with other treatments like corticosteroids for enhanced effectiveness

Key Study Findings

Review
Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments.
Dose: None или: None Outcome: None Эффект: None None

Популяция: women with androgenetic alopecia (female pattern hair loss)

Case Reports n=1
Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case …
Dose: None или: None Outcome: hair regrowth in severe alopecia areata Эффект: None None

Популяция: patient with severe alopecia areata with suboptimal response to tofacitinib

review
Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations.
Dose: Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5 или: Placebo Эффект: Comparable efficacy to topical minoxidil; hypertrichosis 24%, shedding 16-22%, peripheral edema 2% None
Review
Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities.
Dose: None или: None Outcome: None Эффект: None None

Популяция: None

review
The Use of Light-Based Therapies in the Treatment of Alopecia.
Dose: Low-level light therapy (LLLT) various devices and wavelengths; combined with minoxidil or finasteri или: Placebo Эффект: LLLT improves hair density in AGA; potential to prolong anagen phase in telogen effluvium; may promo None
retrospective cohort study n=321
Asynchronous Teledermatology for Non-Scarring Alopecia: A Retrospective Study.
Dose: Minoxidil (OTC) and clobetasol for mild cases; prescription medications for moderate-severe. Specifi или: Placebo Эффект: 91.3% received definitive remote diagnosis; only 8.7% required in-person follow-up. AA most common ( None

Key Statistics

122

Исследования

27416

Участники

Positive

A

Оценка

Referenced Papers

American journal of … 2026 1 цитирований
Expert opinion on … 2025 11 цитирований
Cureus 2025 7 цитирований
Dermatologic clinics 2025 5 цитирований
Pediatric dermatology 2025 5 цитирований
Journal of the … 2025 2 цитирований
Frontiers in pharmacology 2025 2 цитирований
Journal of the … 2025 1 цитирований
International journal of … 2025 1 цитирований
Journal of clinical … 2025 1 цитирований
Archives of dermatological … 2025
Journal of the … 2024 85 цитирований
International journal of … 2024 39 цитирований
Lasers in medical … 2024 10 цитирований
Paediatric drugs 2024 10 цитирований
American family physician 2024 8 цитирований
Skin health and … 2024 7 цитирований
Journal of the … 2024 7 цитирований
Life (Basel, Switzerland) 2024 4 цитирований
The Journal of … 2024 2 цитирований
Archives of dermatological … 2023 16 цитирований
Skin appendage disorders 2023 7 цитирований
Medicine 2023 3 цитирований
The Cochrane database … 2023 2 цитирований
The Journal of … 2022 170 цитирований
Journal of the … 2022 90 цитирований
Dermatology and therapy 2022 43 цитирований
Pharmaceutics 2022 36 цитирований
The Korean journal … 2022 19 цитирований
Skin appendage disorders 2022 7 цитирований
Human psychopharmacology 2022 7 цитирований
JAAD case reports 2022 2 цитирований
The American Journal … 2022 2 цитирований
Clinical reviews in … 2021 304 цитирований
Journal of the … 2021 203 цитирований
Clinical and experimental … 2021 130 цитирований
Journal of the … 2021 63 цитирований
Journal of dermatological … 2021 51 цитирований
Dermatologic therapy 2021 30 цитирований
American journal of … 2020 127 цитирований
International journal of … 2020 58 цитирований
The Journal of … 2020 33 цитирований
Recent patents on … 2020 5 цитирований
The journal of … 2020 3 цитирований
The Australasian journal … 2019 152 цитирований
American journal of … 2019 84 цитирований
Journal of the … 2019 50 цитирований
Expert opinion on … 2019 34 цитирований
Journal of cosmetic … 2019 13 цитирований
Klinicka onkologie : … 2019 11 цитирований
Journal of the … 2018 114 цитирований
International journal of … 2018 93 цитирований
Journal of cosmetic … 2018 13 цитирований
Dermatology online journal 2018
American family physician 2017 141 цитирований
Lasers in medical … 2017 43 цитирований
American journal of … 2017 32 цитирований
Actas dermo-sifiliograficas 2017 17 цитирований
Deutsches Arzteblatt international 2016 99 цитирований
Skinmed 2016 2 цитирований
Current problems in … 2015 322 цитирований
The Medical clinics … 2015 66 цитирований
Canadian family physician … 2015 31 цитирований
Seminars in cutaneous … 2015 27 цитирований
The journal of … 2015 25 цитирований
Current problems in … 2015 18 цитирований
Der Internist 2015
Lasers in surgery … 2014 243 цитирований
American journal of … 2014 82 цитирований
Expert opinion on … 2014 57 цитирований
Giornale italiano di … 2014 18 цитирований
Giornale italiano di … 2014
International journal of … 2013 61 цитирований
Recent patents on … 2011 6 цитирований
Seminars in cutaneous … 2009 85 цитирований
American family physician 2009
The Cochrane database … 2008 222 цитирований
Current opinion in … 2008 31 цитирований
International journal of … 2007 185 цитирований
Alopecia areata. Case Report
Dermatology nursing 2007
The Australasian journal … 2006
Journal of the … 2005 44 цитирований
Cleveland Clinic journal … 2005
Praxis 2003 28 цитирований
American family physician 2003 2 цитирований
American family physician 2003
American journal of … 2000 28 цитирований
International journal of … 1999 16 цитирований
Dermatologic clinics 1998 121 цитирований
American family physician 1990
Dermatologic clinics 1987
Journal of the … 1984 122 цитирований
Journal of the … 1984
Archives of dermatology 1984

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Часто используемые дозировки

topical:
2-5% solution, twice daily

Верхний предел: 5% topical solution

Дозировки, изученные в исследованиях

Дозировка Длительность Эффект N
None -- Neutral --
None -- Positive 1
Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5 -- Positive --
None -- Mixed --
Low-level light therapy (LLLT) various devices and wavelengths; combined with minoxidil or finasteri -- Positive --
Minoxidil (OTC) and clobetasol for mild cases; prescription medications for moderate-severe. Specifi -- Positive 321
None -- Mixed --
None -- Mixed 1

Лучшее время приёма: Apply to dry scalp morning and evening, at least 4 hours before bed

Safety & Side Effects

Зарегистрированные побочные эффекты

  • Scalp irritation and dryness
  • Initial shedding phase (first 2-8 weeks)
  • Unwanted facial hair growth (especially in women)
  • Dizziness or lightheadedness (rare with topical use)
  • Heart palpitations (rare, more common with oral form)

Известные взаимодействия

  • Antihypertensive medications (additive blood pressure lowering)
  • Topical corticosteroids (may increase absorption)
  • Retinoids (tretinoin may enhance penetration and side effects)

Допустимый верхний уровень потребления: 5% topical solution

Всегда консультируйтесь с врачом перед началом приёма любых добавок.Всегда консультируйтесь с лечащим врачом перед началом приёма любой добавки.

Frequently Asked Questions

Does Minoxidil help with Alopecia Areata?
Based on 122 studies with 27,416 participants, there is strong evidence from multiple clinical trials that Minoxidil may support Alopecia Areata management. Our evidence grade is A (Strong Evidence).
How much Minoxidil should I take for Alopecia Areata?
Studies have used various dosages. A commonly studied range is 2-5% solution, twice daily. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Minoxidil?
Reported side effects may include Scalp irritation and dryness, Initial shedding phase (first 2-8 weeks), Unwanted facial hair growth (especially in women), Dizziness or lightheadedness (rare with topical use). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Minoxidil and Alopecia Areata?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 122 peer-reviewed studies with 27,416 total participants. The overall direction of effect is positive.

Related Evidence

Отказ от ответственности FDA: Данные утверждения не были оценены Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов (FDA). Продукты и информация на этом сайте не предназначены для диагностики, лечения, излечения или профилактики каких-либо заболеваний. Представленные оценки доказательности основаны на нашем анализе опубликованных рецензируемых исследований и не являются медицинской консультацией. Всегда консультируйтесь с лечащим врачом перед началом приёма любых добавок.